Showing results (121-130 of 237) with videos related to
Sort By:
Pageof 24
Oncotarget|June 23, 2018
Overcoming drug-tolerant cancer cell subpopulations showing AXL activation and epithelial-mesenchymal transition is critical in conquering ALK-positive lung cancerShinji Nakamichi, Masahiro Seike, Akihiko Miyanaga, et al.Cancers|November 9, 2024
Serum CYFRA 21-1 as a Prognostic Marker in Non-Small-Cell Lung Cancer Patients Treated with Immune Checkpoint InhibitorsKeiki Miyadera, Sho Kakuto, Mayu Sugai, et al.Journal of Nippon Medical School = Nippon Ika Daigaku Zasshi|October 1, 2020
A Possible, Non-Invasive Method of Measuring Dynamic Lung Compliance in Patients with Interstitial Lung Disease Using PhotoplethysmographyKenichiro Atsumi, Yoshinobu Saito, Toru Tanaka, et al.Anticancer Research|August 5, 2006
Phase I/II study of paclitaxel + carboplatin for refractory or recurrent non-small cell lung cancerAkihiko Gemma, Masahiro Seike, Seiji Kosaihira, et al.International Journal of Oncology|April 10, 2014
Significance of osteopontin in the sensitivity of malignant pleural mesothelioma to pemetrexedSusumu Takeuchi, Masahiro Seike, Rintaro Noro, et al.International Journal of Molecular Sciences|April 30, 2021
Long Non-Coding RNA CRNDE Is Involved in Resistance to EGFR Tyrosine Kinase Inhibitor in EGFR-Mutant Lung Cancer via eIF4A3/MUC1/EGFR SignalingSatoshi Takahashi, Rintaro Noro, Masahiro Seike, et al.Molecular Cancer Therapeutics|September 10, 2015
Inhibition of ABCB1 Overcomes Cancer Stem Cell-like Properties and Acquired Resistance to MET Inhibitors in Non-Small Cell Lung CancerTeppei Sugano, Masahiro Seike, Rintaro Noro, et al.International Journal of Clinical Oncology|February 16, 2020
A phase I and extension study of S-1 and carboplatin for previously untreated patients aged 75 years or more with advanced non-small cell lung cancer -TCOG 1101Takashi Kasai, Kiyoshi Mori, Kazuma Kishi, et al.International Cancer Conference Journal|June 1, 2019
Granuloma-forming interstitial pneumonia induced by nivolumab: a possible immune-related adverse event of the lungTakeru Kashiwada, Yoshinobu Saito, Yuji Minegishi, et al.Antioxidants & Redox Signaling|January 6, 2023
Core Fucosylation Is Required for the Secretion of and the Enzymatic Activity of SOD3 in Nonsmall-Cell Lung Cancer CellsYuki Ohkawa, Masato Kitano, Kento Maeda, et al.Pageof 24